covid
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Oxcarbazepina en el tratamiento de la epilepsia
Información de la revista
Vol. 1. Núm. 3.
Páginas 151-154 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 3.
Páginas 151-154 (enero 2003)
Acceso a texto completo
Oxcarbazepina en el tratamiento de la epilepsia
Visitas
11851
Julio Ramos-Lizana
Unidad de Neurología Pediátrica. Servicio de Pediatría. Hospital Torrecárdenas. Almería. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Ramos Lizana, E. Cassinello Garcia, L.L. Carrasco-Marina, M. Vázquez López, M. Martín González, A. Muñoz Hoyos.
Remisión de la epilepsia tras el comienzo del tratamiento: estudio prospectivo en la infancia.
Rev Neurol, 33 (2001), pp. 1021-1026
[2.]
M.J. McLean, M. Schmutz, A.W. Wamil, H.R. Olpe, C. Portet, K.F. Feldmann.
Oxcarbazepine: mechanisms of action.
Epilepsia, 35 (1994), pp. 59S
[3.]
A.W. Wamil, C. Portet, P.K. Jensen, M. Schmutz, M.J. McLean.
Oxcarbazepine and its monohydroxy metabolite limit action potential firing by mouse central neurons in cell culture.
Epilepsia, 32 (1991), pp. 605S
[4.]
M. Schmutz, F. Brugger, C. Gentsch, M.J. McLean, H.R. Olpe.
Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.
Epilepsia, 34 (1993), pp. 4750S
[5.]
P. Lloyd, G. Flesch, W. Dieterle.
Clinical pharmacology and pharmacokinetics of oxcarbazepine.
Epilepsia, 35 (1995), pp. 103S
[6.]
E.S. Tecoma.
Oxcarbazepine.
Epilepsia, 40 (1999), pp. 37S-46S
[7.]
A. Baruzzi, F. Albani, R. Riva.
Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.
Epilepsia, 35 (1994), pp. 149S
[8.]
S.C. Schachter, B. Vázquez, R.S. Fisher, K.D. Laxer, G.D. Montouris, D.T. Combs-Cantrell, et al.
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures.
Neurology, 52 (1999), pp. 732-737
[9.]
R.G. Sachdeo, K. Edwards, H. Hasegawa.
Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent onset partial epilepsy [abstract].
Neurology, 52 (1999), pp. 391A
[10.]
A. Beydoun, R.C. Sachdeo, W.E. Rosenfeld, G.L. Krauss, N. Sessler, P. Mesenbrink, et al.
Oxcarbazepine monotherapy for partial onset seizures: a multicenter, double-blind, clinical trial.
Neurology, 54 (2000), pp. 2245-2251
[11.]
R.C. Sachdeo, A. Beydoun, S.C. Schachter, B. Vázquez, N. Schaul, P. Mesenbrink, et al.
Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.
Neurology, 57 (2001), pp. 864-871
[12.]
K.J. Reinikainen, T. Keränen, T. Halonen, H. Komulainen, P.J. Riekkinen.
Comparison of oxcarbazepine and carbamazepine: a double-blind study.
Epilepsy Res, 1 (1987), pp. 284-289
[13.]
M. Dam, R. Ekberg, Y. Loyning, O. Waltimo, K. Jakobsen.
(The Scandinavian Oxcarbazepine Study Group) A double- blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.
Epilepsy Res, 3 (1989), pp. 70-76
[14.]
W. Christe, G. Kramer, U. Vigonius, H. Pohlmann, B.J. Steinhoff, M.J. Brodie, et al.
A double-blind controlled trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
Epilepsy Res, 26 (1997), pp. 451-460
[15.]
P.A. Bill, U. Vigonius, H. Pohlmann, C.A. Guerreiro, S. Kochen, D. Saffer, et al.
A double-blind controlled trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy.
Epilepsy Res, 27 (1997), pp. 195-204
[16.]
M.M. Guerreiro, U. Vigonius, H. Pohlmann, M.L. De Manreza, N. Fejerman, S.A. Antoniuk, et al.
A double-blind controlled trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.
Epilepsy Res, 27 (1997), pp. 205-213
[17.]
G. Barcs, E.B. Walker, C.E. Elger, A. Scaramelli, H. Stefan, Y. Sturm, et al.
Oxcarbazepine placebo-controlled, doseranging trial in refractory partial epilepsy.
Epilepsia, 41 (2000), pp. 1597-1607
[18.]
T.A. Glauser, M. Nidro, T. Sachdeo, L.A. Pasteris, S. Weinstein, B. Abou-Khalil, et al.
Adjunctive therapy with oxcarbazepine in children with partial seizures.
Neurology, 54 (2000), pp. 2237-2244
[19.]
E. Gaily, M.L. Granström, E. Liukkonen.
Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
J Intel Disab Res, 42 (1998), pp. 415S
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos